Работы, цитирующие эту работу

Работ: 2

Работа: ctDNA can detect minimal residual disease in curative treated non-small cell lung cancer patients using a tumor agnostic approach

1. Prognostic value of postoperative circulating tumor DNA for recurrence-free survival in resected non-small cell lung cancer: a systematic review and meta-analysis

   Atta Ullah Khan, Intizor Avazmetova, Mukhayya Ruzieva +4

   СтатьяCancer Genomics and DiagnosticsClinical & Translational Oncology2025Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.316167

2. Circulating biomarkers in bladder cancer: emerging evidence and future directions for personalized therapy

   Tareq Nayef AlRamadneh, Ahmed Faisal Mutee, Aziz Kubaev +4

   СтатьяBladder and Urothelial Cancer TreatmentsClinica Chimica Acta2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.009920